Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Khokhar

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Journal of Inorganic Biochemistry|March 7, 2003
Preparation, characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)]Uday Mukhopadhyay, John Thurston, Kenton H Whitmire, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatinZ H Siddik, G Thai, M Yoshida, et al.
Journal of Microencapsulation|January 1, 1994
Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical useR Perez-Soler, K Francis, S al-Baker, et al.
Anti-Cancer Drug Design|December 1, 1994
Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivoZ H Siddik, G Thai, M Yoshida, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in miceY Kido, A R Khokhar, M Yoshida, et al.
Molecular Biotherapy|December 1, 1990
Detection of cellular platinum using the monoclonal antibody 1C1K Nishikawa, R A Newman, L Murray, et al.
Cancer Research|August 15, 1988
Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesiclesR Perez-Soler, L Y Yang, B Drewinko, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumorsM Yoshida, A R Khokhar, Y P Zhang, et al.
Cancer Research|October 15, 1993
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cellsI Han, Y H Ling, S al-Baker, et al.
Journal of the National Cancer Institute|November 1, 1986
Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesiclesR Perez-Soler, A R Khokhar, P Claringbold, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Journal of Inorganic Biochemistry|March 7, 2003
Preparation, characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)]Uday Mukhopadhyay, John Thurston, Kenton H Whitmire, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatinZ H Siddik, G Thai, M Yoshida, et al.
Journal of Microencapsulation|January 1, 1994
Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical useR Perez-Soler, K Francis, S al-Baker, et al.
Anti-Cancer Drug Design|December 1, 1994
Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivoZ H Siddik, G Thai, M Yoshida, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in miceY Kido, A R Khokhar, M Yoshida, et al.
Molecular Biotherapy|December 1, 1990
Detection of cellular platinum using the monoclonal antibody 1C1K Nishikawa, R A Newman, L Murray, et al.
Cancer Research|August 15, 1988
Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesiclesR Perez-Soler, L Y Yang, B Drewinko, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumorsM Yoshida, A R Khokhar, Y P Zhang, et al.
Cancer Research|October 15, 1993
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cellsI Han, Y H Ling, S al-Baker, et al.
Journal of the National Cancer Institute|November 1, 1986
Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesiclesR Perez-Soler, A R Khokhar, P Claringbold, et al.
Pageof 10